$Vaccinex Inc.(VCNX)$ and $Merck(MRK)$ partnership has potential....

This stock has been trending on stock screeners for a little while now. The price is very volatile, and speculators could easily Ignite the flames to send this stock rocketing up in price with some good news ......

With a very low turnover of shares. Small market cap, and a interesting drug in trial to slow Alzheimer’s disease this could have the potential of a blockbuster share to own. Pepinemab is so far well tolerated in the small trial of 50 patients, and should reach its one year conclusion of trials in June. Then potential around another 3 months to make a final report on the beginning of September. It has been working with Merck, one of the biggest pharmaceutical companies in the world so there is potentially more funding available if they can show promise with pepinemab. Buyout is also good scenario . They have raised enough funds to keep themselves going until the trial is finished. The insiders are still buying up shares, even with the price going down. They seem to believe in the potential results of the research so far.This is my riskiest investment for 2024. Only invest what you can afford too loose. Happy trading!